https://www.selleckchem.com/pr....oducts/dihydroethidi
BACKGROUND PPOS protocols, initially described for FP in women with cancer, have many advantages compared to antagonist protocols. PPOS protocols were not evaluated for women with endometriosis. The objective of the study was to describe fertility preservation outcomes in women with endometriosis and to compare an antagonist protocol with a Progestin-Primed Ovarian Stimulation (PPOS) protocol. METHOD We conducted a prospective cohort study associated with a cost-effectiveness analysis in a tertiary-care university hospital. The